Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers

Kavithamani K1, Sowmya S1, Shanmugasamy K1

  • 1Department of Pathology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (SBV) University, Pondicherry, IND.

Cureus
|May 24, 2023
PubMed

Insights

Tuberculoid leprosy (TT) shows increased macrophage activation, indicated by higher expression of CD1a and Factor XIIIa dendritic cells, correlating with a lower bacillary index compared to lepromatous leprosy (LL).

Area of Science:

  • Immunology
  • Dermatology
  • Pathology

Background:

  • Leprosy presents diverse clinical forms based on patient immunity, ranging from tuberculoid (TT) to lepromatous (LL).
  • Understanding macrophage activation is crucial for leprosy classification and management.

Purpose of the Study:

  • To assess macrophage activation in the leprosy spectrum using CD1a and Factor XIIIa immunohistochemical markers.
  • To correlate macrophage expression with the morphological spectrum and bacillary index in leprosy.

Main Methods:

  • Observational study design.
  • Immunohistochemical analysis of CD1a and Factor XIIIa markers on leprosy biopsy samples.

Main Results:

  • Higher expression of CD1a (epidermal dendritic cells) and Factor XIIIa (dermal dendritic cells) was observed in Tuberculoid Leprosy (TT) compared to Lepromatous Leprosy (LL).
  • CD1a staining intensity was 70% in TT versus 33% in LL.
  • Factor XIIIa expression was 90% in TT versus 66% in LL.

Conclusions:

  • Increased dendritic cell numbers and staining intensity in the tuberculoid spectrum suggest heightened macrophage activation.
  • This macrophage activation may explain the lower bacillary index observed in Tuberculoid Leprosy.
Abstract